The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

Shearman, M S

The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. [electronic resource] - Journal of neurochemistry Jul 1995 - 218-27 p. digital

Publication Type: Journal Article

0022-3042

10.1046/j.1471-4159.1995.65010218.x doi


Amyloid beta-Peptides--pharmacology
Animals
Cell Membrane Permeability
Coloring Agents
HeLa Cells--metabolism
Humans
Intracellular Membranes--metabolism
Oxidation-Reduction--drug effects
PC12 Cells
Peptide Fragments--pharmacology
Rats
Tetrazolium Salts--chemistry
Thiazoles--chemistry